T. Sever Et Al. , "Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids," 3rd International Multidisciplinary Cancer Research Congress , İstanbul, Turkey, pp.66, 2023
Sever, T. Et Al. 2023. Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids. 3rd International Multidisciplinary Cancer Research Congress , (İstanbul, Turkey), 66.
Sever, T., Ellidokuz, E. B., Başbınar, Y., Ellidokuz, H., & Çalıbaşı Koçal, G., (2023). Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids . 3rd International Multidisciplinary Cancer Research Congress (pp.66). İstanbul, Turkey
Sever, Tolga Et Al. "Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids," 3rd International Multidisciplinary Cancer Research Congress, İstanbul, Turkey, 2023
Sever, Tolga Et Al. "Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids." 3rd International Multidisciplinary Cancer Research Congress , İstanbul, Turkey, pp.66, 2023
Sever, T. Et Al. (2023) . "Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids." 3rd International Multidisciplinary Cancer Research Congress , İstanbul, Turkey, p.66.
@conferencepaper{conferencepaper, author={Tolga Sever Et Al. }, title={Combination Therapy of Beta-Hydroxybutyrate and Oxaliplatin Augments the Treatment Efficacy in Colorectal Cancer Organoids}, congress name={3rd International Multidisciplinary Cancer Research Congress}, city={İstanbul}, country={Turkey}, year={2023}, pages={66} }